Discontinuing Statins After Acute MI Doubles Risk of Death, Say Researchers
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Discontinuing Statins After Acute MI Doubles Risk of Death, Say Researchers

MONTREAL -- August 27, 2008 -- Patients discontinuing statin medication following an acute myocardial infarction (AMI) increase their risk of dying over the next year, according to a study published in the July 29 issue of the European Heart Journal.

Stella Daskalopoulou, MD, Department of Medicine, McGill University, Montreal, Quebec, and colleagues used data from the UK General Practice Research Database to identify patients who survived an AMI and were still alive 3 months later.

They found that those who discontinued their statin medication were 88% more likely to die during the following year compared with those who had never been on the medication.

"Patients who used statins before an AMI and continued to take them after were 16% less likely to die over the next year than those who never used them," said Dr. Daskalopoulou.

"In the general population, the statin discontinuation rate within the first year of prescription is 30%. That's very high," she noted.

"Because statins are preventative drugs, patients may not feel the immediate benefit of taking them and sometimes stop. However, it looks like this might be quite a dangerous practice after an AMI," Dr. Daskalopoulou added

"Regardless of the mechanism or explanation, physicians should be careful when assessing each patient's medication needs … statins in particular should only be withdrawn after an AMI under close clinical supervision."

SOURCE: McGill University

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities